triflupromazine has been researched along with Anemia, Sickle Cell in 1 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, AA | 1 |
| Cornelius, AS | 1 |
| Asakura, T | 1 |
| Horiuchi, K | 1 |
1 other study available for triflupromazine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Comparative studies of phenothiazine derivatives for their effects on swelling of normal and sickle erythrocytes.
Topics: Adult; Anemia, Sickle Cell; Antipsychotic Agents; Antisickling Agents; Calmodulin; Chlorpromazine; E | 1993 |